It's become axiomatic that wide acceptance of non-thermal effects will come from developing biomedical therapies rather than from studying potential hazards. The health effects work is mostly sponsored by those who don't want to find any. And they usually don't (cf: the USAF, EPRI, CTIA, FGF, MMF etc.) So no one should be surprised that the latest advance comes from a small high-tech Israeli company, NovoCure, which is looking for innovative ways to treat cancer. It's a breakthrough --most likely a major breakthrough.

NovoCure uses weak 100-200 kHz electric fields --the company calls them tumor treating fields or TTFields-- to stunt the growth of cancer cells, either by slowing down their proliferation or by killing them off entirely. The company has now demonstrated this in four different cancer cell lines. Even more impressive is that tumor growth has been curtailed in mice, rats and, in a small pilot project, ten human patients with recurrent brain tumors (glioblastoma). .... [continues]

NovoCure video

A NovoCure video showing what happens to a cell when it attempts to divide in the presence of a kHz field
http://sciencenow.sciencemag.org/feature/data/glioblastoma.mov

Read the rest of our latest post on the Microwave News Web site, http://www.microwavenews.com/WeakkHz.html
http://www.microwavenews.com/docs/mwn.6(7)-07.pdf


Louis Slesin, PhD Editor,
Microwave News
A Report on Non-Ionizing Radiation
Phone: +1 (212) 517-2800;
Fax: +1 (212) 734-0316
E-mail: mwn @pobox.com ;
Internet: http://www.microwavenews.com
Mail: 155 East 77th Street, Suite 3D
New York, NY 10021, U.S.A.

--------

Electrifying Brain Cancer
http://www.kimt.com/medical/8580927.html



http://omega.twoday.net/search?q=non-thermal+effects
http://omega.twoday.net/search?q=blood+brain+barrier
http://omega.twoday.net/search?q=brain+tumors
http://omega.twoday.net/search?q=glioblastoma
http://omega.twoday.net/search?q=tumor+cells